Dr J has been in his current position for what, four
Dr J has been in his current position for what, four months. In that short time the following has been accomplished: (1) Hold on HIV lifted, (2) Hold pending protocol approval lifted, (3) Replaced CFO with accomplished M&A veteran, (4) Received green light on submitted protocol for clinical trial, (5) Negotiated new contract with Samsung to delay payment of 48 million for leronlimab production, (6) Entered into agreement with AI company to identify long acting mechanism for lerolimab.
Four months. There is more percolating behind the scenes than we know about. It would be fair to give the guy a little time to move the mountain, say by the end of the month. Then, comes the 'big burrito!"
16
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Xerox Holdings Corporation Under Legal Scrutiny Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors of Xerox Holdings Corporation (NASDAQ: XRX) to inform them about an ongoing class action lawsuit. Investors are reminded of an important deadline for those wanting to assume the role of lead plaintiff in this case. The deadline for...
Continue Reading
UBS dropped a Sell rating on Dr. Reddy's Laboratories (NSE: DRRD) back in 2024, tagging the stock with a price target of INR 5,700.00. You could feel the tension shift in trading rooms as their assessment sparked fresh chatter about the firm’s US base business revenue projections that seem downright optimistic. UBS Questions Revenue Estimates: Too High or Just Right?...
Continue Reading
Assessing Market Position and Performance In the dynamic world of technology hardware, it’s crucial for investors to analyze the competition thoroughly. This article takes a closer look at Apple (NASDAQ: AAPL) and compares its financial metrics and market position against its key competitors in the industry. With this analysis, we aim to provide insights into Apple's...
Continue Reading
Back to School: Parents Brace for Sickness A recent survey shows that as children head back to the classroom, many parents anticipate facing a wave of illnesses at home. Conducted by Boiron, a leader in homeopathic remedies, this nationwide survey reveals parents' concerns about the inevitable germs that come along with the school year. Survey Insights on Parental...
Continue Reading
Scarf Systems, Inc. completed a SOC 2 Type 2 examination back in early 2023, solidifying its place as a frontrunner in data security. This wasn't just some routine check; it was a deep dive into how well Scarf protected customer data and adhered to stringent safety protocols. But here’s the kicker—traders started asking: is this enough to keep investors calm? What’s...
Continue Reading
